COGN posts
FeedPosted Nov 14th 2007 11:20AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Target Corp. (TGT), Hershey Co (HSY), Rio Tinto plc ADS (RTP)
MOST NOTEWORTHY: Hershey Foods, Cognos, Resmed and Artes Medical were today's noteworthy downgrades:
- Hershey (NYSE: HSY) was downgraded to Underperform from Peer Perform at Bear Stearns. Bear believes the new CEO will be under intense pressure to improve operating performance, which will likely lead to higher R&D and marketing spending.
- Cognos (NASDAQ: COGN) was downgraded to Equal Weight from Overweight at Morgan Stanley following the acquisition by IBM (NYSE: IBM).
- ABN Amro lowered its rating on Resmed (NYSE: RMD) to Hold from Buy on valuation following the recent rally.
- Cowen downgraded Artes Medical (NASDAQ: ARTE) to Neutral from Buy following the company's disappointing Q3 report.
OTHER DOWNGRADES:
Posted Nov 13th 2007 11:50AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades
MOST NOTEWORTHY: Cognos, MSC Industrial Direct, Fastenal Company, Royal Kpn and Koppers Holdings were today's noteworthy downgrades:
- Cognos (NASDAQ: COGN) was downgraded to Neutral from Buy at Goldman and at Broadpoint following the acquisition by IBM (NYSE: IBM).
- Baird downgraded MSC Industrial Direct (NYSE: MSM) and Fastenal Company (NASDAQ: FAST) to Neutral from Outperform, as they expect the difficult U.S. manufacturing environment to constrain shares.
- Credit Suisse lowered its rating on Royal Kpn (NYSE: KPN) to Neutral from Outperform based on Getronics integration risk and slowing mobile earnings momentum.
- Koppers Holdings (NYSE: KOP) was downgraded to Buy from Aggressive Buy at KeyBanc based on valuation and concerns on 1H08 comps.
OTHER DOWNGRADES:
Posted Nov 12th 2007 11:40AM by Brent Archer (RSS feed)
Filed under: Deals, Good news, International Business Machines (IBM), Options, Technical Analysis
International Business Machines Corp. (NYSE:
IBM) announced today that it would buy Canadian business-software maker
Cognos Inc. (NASDAQ:
COGN) for $4.9 billion.
The deal would enable IBM to deliver new business insights to a wider set of people across an organization, the company said in a statement. Usually when a company makes an acquisition like this one, its stock drops by at least a little bit. IBM is higher today on this news, which signals investors think this deal was a bargain and good for IBM. If you think that the company won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on IBM.
After hitting a one-year high of $121.46 in October, the stock has fallen off a bit over the past month. IBM opened this morning at $101.89. So far today the stock has hit a low of $100.70 and a high of $102.66. As of 10:50, IBM is trading at $102.51, up $2.26 (2.2%). The chart for IBM looks neutral and improving slightly, while
S&P gives the stock its highest 5 STARS (out of 5) strong buy rating.
Continue reading IBM rises on Cognos (COGN) acquisition
Posted Nov 12th 2007 9:15AM by Douglas McIntyre (RSS feed)
Filed under: Before the bell, Major movement, Barclays plc ADS (BCS)
In the pre-market, Cognos (NASDAQ: COGN) is up almost 8% on news that it is being bought for $5 billion by IBM (NYSE: IBM).
E*Trade (NASDAQ: ETFC) is off 28% on Friday news that it is facing considerable write-downs in the next quarter.
British banking giant Barclays (NYSE: BCS) is up almost 4% after denying that it could face another $10 billion in write-downs.
Stocks trading in the pre-market may open at different prices for the regular session.
Douglas A. McIntyre is an editor at 247wallst.com
Posted Nov 12th 2007 7:37AM by Douglas McIntyre (RSS feed)
Filed under: Deals, International Business Machines (IBM)
IBM (NYSE: IBM) announced that it will buy business intelligence firm Cognos (NASDAQ: COGN) for about $5 billion in cash, or $58 a share. The company currently trades at about $52.
In its press release, IBM said, "The acquisition of Cognos supports IBM's Information on Demand strategy, a cross-company initiative announced on February 16, 2006 that combines IBM's strength in information integration, content and data management and business consulting services to unlock the business value of information."
As hardware fades as IBM's big revenue platform, software and consulting services must replace it. The market may see more of these deals.
Douglas A. McIntyre is an editor at 247wallst.com.
Posted Oct 9th 2007 10:45AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Coca-Cola (KO), PepsiCo (PEP), JetBlue Airways (JBLU)
MOST NOTEWORTHY: Coca-Cola, PepsiCo, Business Objects, Cognos and Cooper Companies were today's noteworthy downgrades:
- Deutsche Bank downgraded Coca-Cola Company (NYSE: KO) and PepsiCo (NYSE: PEP) to Hold from Buy on valuation, as they believe shares reflect prospects for growth.
- Business Objects (NASDAQ: BOBJ) was downgraded to Neutral from Buy at UBS following the acquisition by SAP AG (NYSE: SAP) and to Hold from Buy at Jefferies, as the firm finds the acquisition price fair and does not expect a counter-bid. Soleil believes the SAP offer is reflected in the stock price, and downgraded Business Objects to Hold from Buy.
- Roth Capital downgraded shares of Cognos (NASDAQ: COGN) to Hold from Buy based on recent share appreciation as shares capture a vast majority of a potential takeover bid; Goldman downgraded shares to Neutral from Buy and Jefferies downgraded shares to Hold from Buy on valuation.
- JP Morgan lowered shares of Cooper Companies (NYSE: COO) to Underweight from Neutral. The firm believes Street estimates are too high given a negative mix shift in the company's contact lens business, which could lead to a FY08 EPS shortfall.
OTHER DOWNGRADES:
Posted Sep 28th 2007 11:00AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades,
MOST NOTEWORTHY: BT Group, Luminent Mortage, Cognos, Thor Industries and Watson Pharmaceuticals were today's noteworthy upgrades:
- ING Group upgraded shares of BT Group (NYSE: BT) to Hold from Sell to reflect the company's more stable revenue trend and improving cash flow generation.
- Deutsche Bank upgraded shares of Luminent Mortgage Capital (NYSE: LUM) to Hold from Sell, as they believe the company's portfolio is beginning to stabilize and its liquidity has improved.
- Goldman upgraded Cognos Inc (NASDAQ: COGN) to Buy from Neutral following its Q2 report.
- Thor Industries (NYSE: THO) was raised to Sector Perform from Underperform at RBC Capital Markets. The firm's checks indicate strengthening backlog and lower promotional spending.
- Roth Capital believes Watson Pharmaceuticals (NYSE: WPI) is about to enter a growth phase with Paul Bisaro at the helm and is positive on Silodosin potential. The firm upgraded shares to Buy from Hold.
OTHER UPGRADES:
Posted Jul 17th 2007 10:40AM by Kevin Shult (RSS feed)
Filed under: Before the bell, Analyst reports, Analyst upgrades and downgrades, Good news, American Express (AXP), AMR Corp (AMR), Marriott Intl'A' (MAR), UAL Corp (UAUA), Delta Air Lines (DAL)
MOST NOTEWORTHY: Wilshire Bancorp (WIBC), American Express (AXP), AMR Corp (AMR), Delta Air Lines (DAL) and UAL Corp (UAUA) were some of today's noteworthy upgrades:
- Friedman Billings upgraded shares of Wilshire Bancorp (NASDAQ: WIBC) to Market Perform from Underperform based on valuation.
- Goldman Sachs upgraded shares of American Express (NYSE: AXP) to Buy from Neutral as they believe American's network business is undervalued.
OTHER UPGRADES:
- Cognos Inc (NASDAQ: COGN) was raised to Strong Buy from Outperform at JMP Securities.
- JP Morgan upgraded Lear Corp (NYSE: LEA) to Overweight from Neutral.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).Posted Jun 22nd 2007 11:15AM by Kevin Shult (RSS feed)
Filed under: Before the bell, Analyst upgrades and downgrades, Bad news, Starbucks (SBUX), Abercrombie and Fitch (ANF)
MOST NOTEWORTHY: Select theater stocks, Equity Inns (ENN), Talbots (TLB) and Starbucks (SBUX) filled today's noteworthy downgrade segment:
- Banc of America said summer blockbusters have fallen off faster than they expected and there are fewer mid-tier films to support growth:
- Equity Inns (NYSE: ENN) was cut to Sell from Hold at AG Edwards after the Whitehall acquisition. JMP Securities and Friedman Billings cut shares to Market Perform from Outperform and KeyBanc downgraded Equity Inns to Hold from Buy.
- Matrix USA downgraded Talbots (NYSE: TLB) to Sell from Hold based on the eroding return of capital because of the company using capital to acquire and open new stores. Friedman Billings downgraded shares of
- Starbucks (NASDAQ: SBUX) to Market Perform from Outperform and removed the company from their FBR Top Picks list on expectations that 2H07 same-store sales will no longer improve, removing a catalyst...
OTHER DOWNGRADES:
- Banc of America downgraded Cognos (NASDAQ: COGN) to Neutral from Buy.
- Roth downgraded Fuel Tech Inc (NASDAQ: FTEK) to Hold from Buy.
Analyst summaries provided by
TheFlyOnTheWall.com (subscription required).
Posted May 17th 2007 10:36AM by Kevin Shult (RSS feed)
Filed under: Before the bell, Analyst upgrades and downgrades, Good news
MOST NOTEWORTHY: MGM Mirage (MGM), USA Truck, Inc (USAK), Knightsbridge Tankers Ltd (VLCCF), Monolithic Power Systems, Inc (MPWR) and Stanley, Inc (SXE) topped out today's noteworthy upgrade list:
- Prudential upgraded shares of MGM Mirage (NYSE: MGM) to Overweight from Neutral on valuation, as the firm believes the recent weakness presents a buying opportunity.
- USA Truck Inc (NASDAQ: USAK) was raised to Equal Weight from Underweight at Stephens based on valuation.
- Jefferies upgraded shares of Knightsbridge Tankers Ltd (NASDAQ: VLCCF) to Hold from Underperform to reflect the company's five vessels now operating on long-term time charter contracts and its recent entry into the dry bulk shipping sector.
- Monolithic Power (NASDAQ: MPWR) was upgraded to Buy from Hold at Deutsche Bank following its patent win case against O2Micro International Ltd (OIIM).
- Wachovia upgraded Stanley Inc (NYSE: SXE) to Outperform from Market Perform based on its strong Q4 report and guidance...
OTHER UPGRADES:
- Cognos Inc (NASDAQ: COGN) was upgraded to Outperform from Sector Perform at Pacific Crest.
- Barrington raised X-Rite, Inc (NASDAQ: XRIT) To Outperform from Market Perform.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).Posted Mar 9th 2007 11:02AM by Kevin Shult (RSS feed)
Filed under: Before the bell, Analyst upgrades and downgrades, Good news, Halliburton (HAL), Brinker Intl (EAT), Charles Schwab Corp (SCHW), FedEx Corp (FDX), Office Depot (ODP), Texas Instruments (TXN)
MOST NOTEWORTHY: Brinker International Inc (EAT), National Semiconductor Corp (NSM), and three select transportation stocks were today's more notable upgrades:
- UBS upgraded Brinker International Inc (NYSE: EAT) to Buy from Neutral with a $38 target, citing valuation following the recent sell-off.
- National Semiconductor Corp (NYSE: NSM) was upgraded to Accumulate from Source of Funds with a $28 target at ThinkEquity, following the company's Q3 report and guidance.
- Three transportation companies were upgraded at Stifel: Con-Way Inc (NYSE: CNW), FedEx Corp (NYSE: FDX) and Universal Truckload Services Inc (NASDAQ: UACL) were upgraded to Buy from Hold to reflect attractive valuations.
OTHER UPGRADES:
- Credit Suisse upgraded Office Depot, Inc (NYSE: ODP) to Outperform from Neutral.
- JMP Securities upgraded Texas Instruments Inc (NYSE: TXN) to Market Outperform from Market Perform ahead of the mid-quarter upgrade. Texas Instruments was also upgraded to Buy from Hold at Stifel.
- Calyon Securities upgraded Halliburton Co (NASDAQ: HAL) to Add from Neutral on valuation.
- Bernstein upgraded Charles Schwab Corp (NASDAQ: SCHW) to Outperform from Market Perform.
- BMO Capital Markets upgraded Cognos Inc (NASDAQ: COGN) to Outperform from Market Perform. BMO believes Cognos will receive additional business due to Oracle Corp's (NASDAQ: ORCL) acquisition of Hyperion Solutions Corp (NASDAQ: HYSL) and also see a greater chance that Cognos itself could be acquired.
- Cowen upgraded King Pharmaceuticals (NYSE: KG) to Neutral from Underperform citing Skelaxin's new label approval, which likely delays a generic.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).Posted Mar 1st 2007 1:45PM by Georges Yared (RSS feed)
Filed under: Deals, Competitive strategy, Columns, Oracle Corp (ORCL)
As Tom Taulli wrote earlier, Oracle Corp. (NASDAQ:ORCL) announced its intention to buy Hyperion Solutions Corp. (NASDAQ:HYSL) for $3.3 billion this morning. This will of course trigger speculation that the other two key players in the business intelligence space will go the same route. The players are French-based Business Objects (NASDAQ:BOBJ) and Canada-based Cognos Inc. (NASDAQ:COGN). The bottom line is that all three companies have been in play and facing buy-out rumors for the last three years. The only problem was they could not capture an enhanced valuation until they demonstrated real growth -- top and bottom line.
But what does this signal for Oracle? Oracle is the undisputed worldwide leader in database products. All competitors in the database field are dwarfed by Oracle. The operating margins for Oracle in pure database sales is north of 40%.
However, two problems have emerged for the company these past 4-5 years: 1) Its internally developed applications software has been a disaster, forcing Oracle to purchase Seibel Systems and PeopleSoft. 2) Database margins are being scrutinized by the customer base.
Continue reading Oracle's deal with Hyperion - don't get excited just yet
Next Page >